HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

REACH Compliance: ECHA Zeroes In On Read-Across, Grouping Approaches

This article was originally published in The Rose Sheet

Executive Summary

The roughly 68% of REACH chemical dossiers that lacked crucial safety information in 2017 represent an improved compliance rate compared with previous years, but ECHA soon will be turning to low-tonnage registrations, many from small, inexperienced industry players. The agency expects grouping approaches to play a large role in 2018 registrations and its substance evaluation activities going forward.

You may also be interested in...



ECHA To Ramp Up REACH Compliance Checks, Targeting 30% Of All Registered Substances By 2027

Noncompliance with REACH information requirements remains an issue of concern for European authorities. ECHA aims to attack the problem by increasing the amount of compliance checks it performs while working with industry to drive improvements and national authorities to strengthen enforcement.

REACH Phase-In Registration Is Over. Now What?

After 10 years and nearly 90,000 registrations, the phase-in period for existing chemicals under the EU’s REACH regulation is finished. New chemicals must continue to be registered, and substance dossiers have to kept up to date through ongoing cooperation between registrants, ECHA reminds industry.

BASF Ingredient Case Begs For Verdict: Do REACH Animal Tests Violate Cosmetics Reg?

The European Chemicals Agency says a BASF ingredient, exclusively used in cosmetics, requires a standard animal test, but the firm is concerned that the testing will trigger prohibitions under the EU's Cosmetics Regulation. A Dec. 12 decision from ECHA's Board of Appeal doesn't resolve the matter, but it could get the ball rolling toward an EU court ruling clarifying the relationship between the regulations.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121504

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel